- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Speech Recognition Software Improves Radiology Report Turn-Around Times
Radiology report turn-around times improve with introduction of speech recognition software.
Speech recognition software (SRS) helps improve radiology report turn-around times in community-based hospital practices, according to a study in the Journal of the American College of Radiology.
Researchers from Brigham and Women's Hospital and Harvard Medical School in Boston, Mass., evaluated the utility and effectiveness of SRS in a 150-bed community hospital setting without a radiology training program. Benefits of using SRS have been reported in large academic practices.
The SRS was implemented between May 2011 and July 2011 and report turn-around times and normalized radiologist productivity were assessed before the software was implemented and for five months. The researchers also assessed trend in productivity.
The results showed that median and 80th to 95th percentile report turn-around times decreased substantially following introduction of the SRS (median, from 24 to one hour; 80th percentile, from 60 to 10 hours; 95th percentile, from 165 to 33 hours). The researchers did not detect a significant trend in report turn-around times beyond that of initiation of the software. Normalized radiologist productivity was stable throughout the study period, the authors noted.
The researchers concluded that with implementation of the SRS, there was a 24-fold improvement in median report turn-around time in this setting, without affecting normalized radiologist productivity.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
